Login

Dror Bashan, CEO, Protalix Biotherapeutics Inc 00:00:00

Share On Facebook Share On Twitter

Protalix BioTherapeutics looks to commercialize its Fabry Disease therapy

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
On a Mission to Power SMBs|Graham Carney,Investor,GGV Capital
00:10:00
George Shultz on the Cold War: Reagan's Return to Containment and Its Impact
00:10:00
J. Streicher & Co. Celebrates 91 Years by Ringing NYSE Closing Bell
00:10:00
Atlas Copco CEO on Energy Efficiency and Climate Action | Mats Rahmström, President, Atlas Copco Group.
00:10:00
AMEX Exploration's High-Grade Gold Project Update and Upcoming Catalysts
00:10:00
Invests in seed to growth stage startups that uses tech to disrupt existing markets or create entirely new ones|Aaref Hilaly,Partner,Bain Capital Ventures
00:10:00
Michael Bapis Discusses Client-Centric Wealth Management on TD Ameritrade Network
00:10:00
Interview with Steve Parsons on Restoring Bellevue Gold Mine
00:00:00
All About Acoustic Neuroma: Overview - Mallory J. Raymond, M.D. Otolaryngologist, Mayo Clinic
00:10:00
AES CEO Andrés Gluski discusses his company's strategy for using renewable energy methods to power data centers in an interview with Alix Steel.
00:10:00
Joey Zwillinger on Simplicity & Sustainability: The Allbirds Story | Joey Zwillinger, CEO, Allbirds Inc.
00:10:00
Inflation Stalemate and Its Impact on Federal Reserve Rate Cuts |Russell Price, Chief Economist , Ameriprise Financial Inc.

© 2017 - Neuhu+